C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in C4 Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +4 vs. Q4 2022
- Shares held
- 37.4M
- −1.83M (−4.7%) vs. Q4 2022
- Total value
- $117.5M
- −$113.9M (−49.2%) vs. Q4 2022
- New holders
- 21
- 44 more added
- Sold out
- 17
- 36 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 317,009 | $995.4K | 0.00% | −39,643−11.1% | Reduced |
| Renaissance Technologies LLC | 326,080 | $1.02M | 0.00% | +293,580+903.3% | Added |
| Goldman Sachs Group Inc | 345,583 | $1.09M | 0.00% | +61,631+21.7% | Added |
| Nuveen Asset Management, LLC | 356,609 | $1.12M | 0.00% | −20,915−5.5% | Reduced |
| Nextech Invest AG | 375,857 | $1.18M | 0.49% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 382,216 | $1.20M | 0.00% | +2,434+0.6% | Added |
| Northern Trust Corp | 384,604 | $1.21M | 0.00% | −14,428−3.6% | Reduced |
| Two Sigma Advisers, LP | 400,300 | $1.26M | 0.00% | +138,800+53.1% | Added |
| Citadel Advisors LLC | 527,154 | $1.66M | 0.00% | +147,654+38.9% | Added |
| AQR Capital Management LLC | 606,465 | $1.90M | 0.00% | +331,373+120.5% | Added |
| Jacobs Levy Equity Management, Inc | 723,701 | $2.27M | 0.01% | −4,970−0.7% | Reduced |
| State Street Corp | 774,221 | $2.43M | 0.00% | −1,673,376−68.4% | Reduced |
| Geode Capital Management, LLC | 840,778 | $2.64M | 0.00% | +43,486+5.5% | Added |
| TCG Crossover Management, LLC | 1,250,000 | $3.92M | 0.77% | +1,250,000 | New |
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $5.16M | 0.64% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,112,526 | $6.63M | 0.00% | +47,611+2.3% | Added |
| Soleus Capital Management, L.P. | 2,387,020 | $7.50M | 0.93% | −53,823−2.2% | Reduced |
| Price T Rowe Associates Inc | 2,875,374 | $9.03M | 0.00% | −49,879−1.7% | Reduced |
| BlackRock Inc. | 3,696,742 | $11.6M | 0.00% | +75,609+2.1% | Added |
| Wasatch Advisors Inc | 5,716,021 | $17.9M | 0.11% | −59,677−1.0% | Reduced |
| ArrowMark Colorado Holdings LLC | 6,380,880 | $20.0M | 0.23% | +578,009+10.0% | Added |
| RTW Investments, LP | 0 | $0 | 0.00% | −2,819,472−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −345,969−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −177,858−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −36,000−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −18,574−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −11,859−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,526−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,379−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,685−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −185−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |